OpenAI, Perturb AI, and Scripps Research used thousands of AI agents powered by GPT-Rosalind to analyze millions of mouse brain cells in 32 minutes. The agents connected gene disruption effects with scientific literature, uncovering unexpected biological connections for Alzheimer's and Parkinson's research. The work demonstrates AI's ability to explore large biological experiments beyond what scientists can thoroughly investigate.
Modern experiments generate far more data than researchers can review, with thousands of genes altered across millions of cells. AI helps uncover promising leads that might otherwise be missed. The team divided analysis among AI agents, each investigating a gene disruption, analyzing cellular responses, and searching literature.
Reports were combined into a reasoning atlas linking genes, cellular effects, publications, and biological mechanisms. The team estimated comparable human analysis would take months to a year. Agents reproduced findings while uncovering additional leads, with novelty assessments aligning with blinded human experts.
These findings help prioritize further experiments to test proposed biological mechanisms. Some insights point to new leads for understanding brain disease, including unexpected differences in how disease-linked genes affect brain cells and a potential connection between cholesterol regulation and neurodegeneration. The reasoning atlas is available for scientists to compare related genes and identify promising leads.
New discoveries emerge when researchers from different fields connect familiar ideas in unexpected ways. AI can significantly scale these connections by linking new data with knowledge scattered across disciplines, turning more data into testable hypotheses for future treatments.
Source: OpenAI Blog · Summarized by HeadlinesBriefing